BlackRock Fund Advisors’s Axsome Therapeutics AXSM Stock Holding History

BlackRock Fund Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.42M	Buy	358,046 +56,848	+19%	+$399K	﹤0.01%	3129
2016 Q3	$2.37M	Buy	301,198 +12,367	+4%	+$93.6K	﹤0.01%	3119
2016 Q2	$2.18M	Buy	288,831 +276,322	+2,209%	+$2.55M	﹤0.01%	3169
2016 Q1	$108K	Sell	12,509 -1,220	-9%	-$11.2K	﹤0.01%	3646
2015 Q4	$127K	Buy	+13,729	New	+$121K	﹤0.01%	3677

Other funds holding AXSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's AXSM Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Axsome Therapeutics (AXSM) stake by 19% in Q4 2016, buying an estimated $399K and bringing the position to 358,046 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #3129.

BlackRock Fund Advisors first reported a position in AXSM in Q4 2015 and has held it in 5 quarters since. 41 funds tracked by Wall St. Rank hold AXSM as of Q4 2016.

BlackRock Fund Advisors held 358,046 shares of Axsome Therapeutics worth $2.42M as of Q4 2016.
BlackRock Fund Advisors bought 56,848 Axsome Therapeutics shares in Q4 2016, an estimated $399K.
Axsome Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3129 holding.
BlackRock Fund Advisors first reported a position in Axsome Therapeutics in Q4 2015 and has held it in 5 quarters since.
41 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.